Brea, CA, United States
Brea, CA, United States

Beckman Coulter Inc., is an American company that makes biomedical laboratory instruments. Founded by Caltech professor Arnold O. Beckman in 1935 as National Technical Laboratories to commercialize a pH meter that he had invented, the company eventually grew to employ over 10,000 people, with $2.4 billion in annual sales by 2004. Its current headquarters are in Brea, California. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

News Article | July 27, 2017
Site: www.prnewswire.com

"We designed this system of products in direct response to the daily concerns faced by our customers," said Christoph Moellers, vice president and general manager, workflow and information technology solutions business unit. "Not only are laboratory professionals today tasked with ensuring timely, reliable results to support patient care, but also they must manage the day-to-day operations in the laboratory. We saw that by giving them the right kind of information at the right time, we could greatly alleviate some of the pressures they face." The DxONE suite of information management solutions form a cohesive system of products designed to improve efficiency, give insight into operations throughout an entire network and create a more comprehensive understanding of laboratory performance. "Technology has given us the ability to gather vast amounts of data," said Christoph Moellers. "The challenge has been in taking all the data that is being collected and presenting it in a way that gives the laboratory the greatest benefit. We believe this unique combination of solutions does that, empowering laboratory personnel to achieve their operational and care goals." The DxONE integrated system of information management solutions represents Beckman Coulter Diagnostics' role as an information and test consolidation partner for laboratories seeking to create better efficiencies and quality in patient care. It further expands the portfolio of clinical diagnostic solutions offered by the diagnostic companies of Danaher Corporation, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer, and SCIEX Diagnostics. The breadth of this portfolio extends from the established to novel diagnostic technologies for clinical and anatomic pathology laboratories and point-of-care testing. With a rich history and a tradition of innovation, the diagnostic companies of Danaher remain committed to developing of new and unique diagnostic approaches for better, integrated patient care, and to helping the healthcare systems build comprehensive and efficient diagnostic services with high degree of automation, standardization and connectivity. About Beckman Coulter Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For over 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person. Disclaimer: Not available in all markets. Check with your local representative for availability. ©2017 Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.


News Article | August 8, 2017
Site: www.prweb.com

This webinar, as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, will discuss Phase Analysis Light Scattering (PALS) and Raman spectroscopy methods to characterize the H4-IC31 vaccine formulation. The PALS method can be used to assess vaccine product quality and consistency regarding particle size, zeta potential and conductivity. These parameters can differentiate between the IC31® adjuvant and the H4-IC31 vaccine candidate; hence, the method can serve as a control during vaccine formulation. A tuberculosis (TB) vaccine consisting of a recombinant fusion protein combined with a novel synthetic cationic adjuvant, is in development. Beckman Coulter Life Sciences has selected two speakers for this event; Dr. Sasmit Deshmukh, an associate scientist at SGS Canada and Sanofi Pasteur Ltd., and Dr. Marina Kirkitadze, Head of Biophysics and Conformation Unit at Sanofi Pasteur Ltd, will both present during this webinar. Deshmukh received his doctorate in chemistry from Concordia University in Montreal. With more than 10 years experience, his work has focused on extensive multidisciplinary research experience in chemistry, biochemistry and biophysics. He currently serves as an associate scientist at SGS Canada and Sanofi Pasteur Ltd. As a 15-year veteran of the vaccine industry, Kirkitadze currently is the Deputy Director and Head of Biophysics and Conformation Unit of Analytical R&D Biochemistry at Sanofi Pasteur. She received her doctorate in biological sciences from the Institute of Protein Research at the Russian Academy of Sciences. LabRoots will host the educational webinar on August 31, 2017, commencing at 7:00 a.m. PDT, 10:00 a.m. EDT. To read more on this event or to register for free, click here. About Beckman Coulter Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences. The company develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. Scientists use Beckman Coulter’s Life Science research instruments to study complex biological problems, including causes of disease and potential new therapies or drugs. About LabRoots LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


News Article | August 2, 2017
Site: www.prweb.com

Presented as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, this webinar is aimed at describing the technique of counterflow centrifugal elutriation and how a wide range of scientific areas can apply this tool to advance their investigations. CCE is a well-known technique used commonly several decades ago in scientific research. In this technique, cells are subjected to two opposing forces, centrifugal force and fluid velocity, which results in the separation of cells by size and density. With the advent of more sophisticated and automated technologies, the technique of CCE has taken a back-seat. There is a need to revive this technology in order to benefit the most from its unique capabilities. This technique is especially helpful in studying aspects of primary acute lymphoblastic leukemia cells. The limitations of the technique will also be discussed. The detailed methodology presented should facilitate application and exploration of the technique to other types of cells. The team at Beckman Coulter Life Sciences has arranged to have Dr. Anisha Rathi, a post-doctoral research associate at St Jude Children's Research Hospital, as the speaker for this event. After completing a Master's degree in virology, Rathi went on to earn a doctorate in biochemistry and molecular biology from the University of Arkansas for Medical Sciences. In July 2016 she joined the laboratory at St. Jude Children's Research Hospital for a postdoctoral position, where she works on the development of anti-cancer strategies in hematological and solid tumors. Her current research mainly focusses on targeting anti-apoptotic BCL-2 family proteins as a strategy to improve survival in ALL and neuroblastoma. LabRoots will host the event August 17, 2017, beginning at 10:00 a.m. PDT, 1:00 p.m. EDT. To learn more details on this webinar or to register for free, click here. About Beckman Coulter: Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences. The company develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. Scientists use Beckman Coulter’s Life Science research instruments to study complex biological problems, including causes of disease and potential new therapies or drugs. About LabRoots: LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


"We look forward to collaborating with our colleagues and partners at AACC this year to further relationships and deepen understanding. We know that, as significant changes occur in the healthcare landscape, our clinical partners face a host of challenges that require new ways of thinking," said Arnd Kaldowski, president, Beckman Coulter Diagnostics and Group Executive Diagnostics for Danaher. "We believe that patient care begins with the clinical laboratory. Helping serve patients in the safest and most efficient manner is our job, and, in fact, it is our vision to advance healthcare for every person." At the heart of the Beckman Coulter Diagnostics Difference, are the company's comprehensive high-quality clinical diagnostics solutions—exemplified by several new products featured in the booth this year, including the: The launch of these new products further expands portfolio spanning multiple disciplines, further expands the clinical diagnostic solutions available to customers through Danaher Corporation's network of companies, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer and SCIEX Diagnostics. The breadth of offerings extends from established to highly advanced diagnostic technologies for clinical and anatomic pathology laboratories and point-of-care testing. With a rich history and tradition of innovation, the diagnostic companies of Danaher remain committed to helping healthcare systems build comprehensive and efficient diagnostic services to meet the evolving demands of highly integrated and coordinated healthcare delivery models. Laboratorians and healthcare professionals can learn more about Beckman Coulter Diagnostics solutions by participating in the company-hosted educational programs and in-booth presentations listed below. Detailed information is available here. Tuesday, August 1, 1:00 to 2:00 pm Sepsis and the Hematology Laboratory In this session, the clinical and laboratory-related characteristics of sepsis are described, with special emphasis on hematologic manifestations of sepsis. Speaker: Mike Samoszuk, M.D., Beckman Coulter Wednesday, August 2, 10:30 am to 12:00 pm The ASSESS Trial: A Multi-instrument Evaluation of 13 Commercial Troponin Assays, Sample Analysis in a Common Cohort of Samples Moderator: Robert Christenson, Ph.D., University of Maryland School of Medicine Speakers: Allison Chambliss, Ph.D., Keck School of Medicine of University of Southern California; Paramjit Sandhu, M.D., MPH, Centers for Disease Control and Prevention; Alan Wu, Ph.D., University of California San Francisco General Hospital Procalcitonin and its Role as a Biomarker for the Management of Sepsis                  Sherry Faye, Ph.D.      Tuesday, August 1, 12:00 pm New Challenges for Microbiology Laboratories in Antibiotic Susceptibility Testing Barbara Zimmer, Ph.D.             Tuesday, August 1, 1:00 pm H&H Testing: The Rule of Three Is Still Relevant Ahmed Bentahar M.D., Ph.D. Tuesday, August 1, 2:00 pm High-sensitivity Cardiac Troponin: What Does It Mean for Your Laboratory, Your Clinicians and Your Patients? Peter Kavsak Ph.D., FCACB, FACB, FCCS                 Tuesday, August 1, 3:00 pm Leveraging Service and Care Through Real-time Analysis of Provider Relationships and Behavior   Connor Billing Thursday, August 3, 10:00 am 9:30 am to 5:00 pm │ Tuesday, August 1 or Wednesday, August 2 Authors will be available at posters from 12:30 to 1:30 pm for discussion with attendees. A Prospective Observational Study of the Clinical Decision Impact on the Prostate Health Index (phi) Test in a Urology Practice Setting (A-141) A Comparison of the New Beckman Coulter DxC 700 AU Clinical Chemistry System to the UniCel DxC 800 Synchron Clinical Systems (B-440) Characteristics of the New Beckman Coulter Access hsTnI Assay (TBD) Biomarker Changes in Adult Men with Low Testosterone (low-T) (A-172) Improvement to Workflow in Reagent Dispense System Design in the New Beckman Coulter DxM MicroScan WalkAway System (B-075) Multicenter Evaluation of Imipenem MIC Results for Gram Negative Bacilli Using MicroScan Dried Gram Negative MIC Panels (A-123) Easy as 1, 2, 3? Trimester-specific TSH Reference Intervals in a Well-Characterized Population Using the Beckman Coulter (3rd IS) Immunoassay (TBD) Early Development of DxONE Insights, a Tool to Enhance Data-Driven Decision Making to Improve Laboratory Efficiency (B-028) Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For more than 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care, because we believe when efficiency and clinical outcomes are improved, patients benefit, and we can move healthcare forward for every person. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. *Pending 510(k) clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use in the United States. **Under development. The performance characteristics of this product have not been established. ***Not yet available for in vitro diagnostic use. Pending achievement of CE compliance, Canadian Licensure and other regulatory registrations. REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license. Cepheid and GeneXpert are trademarks of Cepheid in the United States and other countries.


News Article | August 10, 2017
Site: www.prnewswire.com

"The advancements in our Access 2 immunoassay system are a great example of how our research and development team listened to our customers and enhanced an already high-performing product to best serve the needs of clinical laboratories," said John Blackwood, senior vice president, chemistry and immunoassay business unit, Beckman Coulter Diagnostics. "The Access 2 provides remote PROService connectivity, on-the-fly reagent and consumable loading, proven reliability and delivers up to 100 tests per hour. Together these features and benefits save laboratories precious time and enables physicians to deliver responsive care for patients." Ideal for small- to medium-sized physician office laboratories, community hospitals and independent references labs or as a back-up to other primary immunoassay systems, the Access 2 is a reliable and robust system. It is designed with sample probe obstruction detection and remote monitoring capability for instrument diagnostics, maintains greater than 98 percent system availability and delivers less than 1.1 emergency service calls per year. Beckman Coulter Diagnostics offers an extensive diagnostic testing menu for use on the Access 2 immunoassay system, with tests that cover a range of disease states to fulfill patient care needs. These tests include, adrenal disorders, anemia, bone metabolism, cardiac-related conditions, diabetes, infectious diseases, reproductive health, endocrinology, thyroid and tumor markers. The enhancements of Access 2 immunoassay system further strengthens  the portfolio of clinical diagnostic solutions offered by the diagnostic companies of Danaher Corporation, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer, and SCIEX Diagnostics. The breadth of this portfolio extends from the established to novel diagnostic technologies for clinical and anatomic pathology laboratories and point-of-care testing. With a rich history and a tradition of innovation, the diagnostic companies of Danaher remain committed to developing of new and unique diagnostic approaches for better, integrated patient care, and to helping the healthcare systems build comprehensive and efficient diagnostic services with high degree of automation, standardization and connectivity. Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For more than 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.


News Article | August 17, 2017
Site: www.prweb.com

A recent report indicates that circa 79 percent of 483 warning letters issued by the FDA to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines their expectations for quality critical instrumentation in the GMP environment in their 21 CFR Part 11 ruling. Presented as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, this webinar takes a look at how quality-critical on-line Total Organic Carbon (TOC) and conductivity instrumentation can be configured to help companies comply with the FDA’s expectations on data integrity, including the use of Microsoft Active Directory and PDF data export. Tony Harrison, a senior marketing manager with Beckman Coulter Life Sciences, will be the speaker for this event. Harrison holds a Bachelor's Degree in electrical & electronic engineering and has extensive background in water system TOC, conductivity and ozone analysis and cleanroom environmental monitoring as well as particle characterization. He has spent the last fifteen years in applied metrology for the pharmaceutical and healthcare manufacturing industries. Prior to that, he worked for companies providing process control automation solutions for manufacturing industries. LabRoots will host this webinar September 5, 2017, beginning at 8:00 a.m. PDT, 11:00 a.m. EDT. To learn more about the Beckman Coulter Life Sciences Virtual Trade Show, the event in particular, or to register for free, click here. About Beckman Coulter Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences. The company develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. Scientists use Beckman Coulter’s Life Science research instruments to study complex biological problems, including causes of disease and potential new therapies or drugs. About LabRoots LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


News Article | June 6, 2017
Site: www.prweb.com

As part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, the latest in analytical methods to measure AAV particles will be discussed in a new webinar. Several examples of AAV vectors analysis will be presented, showing that AUC could be implemented as a routine test to monitor AAV product quality and manufacturing consistency. As gene therapy approaches usually require large amounts of AAV vectors for clinical use, few manufacturing processes have been reported to provide high titer and potent quantities of products. The dose control of AAV vectors is commonly established on titration methods relying either on the quantitation of DNA or transgene expression following cell transduction. Different indirect methods can be used to establish the ratio between full and empty AAV particles. The quantification of full capsids is performed by using qPCR based technology. The total particles can be evaluated by an ELISA assay, spectrometric analysis, ion-exchange chromatography or SDS-PAGE. However, these methods have limitations and are not applicable to all serotypes without performing a new development. This webinar will explore those limitations, as well as methods to quantify simultaneously empty and full AAV particles as well as intermediate species containing fragmented or incomplete vector genome. The team at Beckman Coulter Life Sciences has arranged for Dr. Christine Le Bec, head of analytical development at Genethon, to be the speaker for this webinar. Prior to joining Genethon, Le Bec obtained her doctorate in bio-organic chemistry from the Pierre and Marie Curie University. She joined Genethon in 1997 and currently heads the analytical development department. She is responsible for developing bioassays and setting up advanced analytical tools used for characterization and in release, in-process testing of gene therapy products at early stage development. LabRoots will host the webinar June 28, 2017, beginning at 7:00 a.m. PDT, 10 a.m. EDT. To read more about this event or to register for free, click here. About Beckman Coulter Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences. The company develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. Scientists use Beckman Coulter’s Life Science research instruments to study complex biological problems, including causes of disease and potential new therapies or drugs. About LabRoots LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


"Fast diagnosis and treatment are critical for patients who have become septic," said Mike Samoszuk, M.D., vice president and chief medical officer at Beckman Coulter Diagnostics. "Adding PCT to our chemistry menu offers a tool for managing bacterial infections and sepsis, which should, inform the course and prognosis of the disease and facilitate therapeutic decisions. This addition is a result of our commitment to providing disease-state-management solutions." This assay is the first homogenous PCT assay for use on current Beckman Coulter AU model chemistry analyzers eliminating the need for costly dedicated instrumentation. The assay features a latex-enhanced immunoturbidimetric methodology, which uses multiple monoclonal antibodies for enhanced assay sensitivity and specificity. The high-quality, fully automated PCT assay is available for use with Beckman Coulter AU analyzers, models 480, 680 and 5800. "Healthcare providers face challenges in timely diagnosis of bacterial infections and sepsis," said Jack Zakowski, PhD, FACB, director, scientific affairs at Beckman Coulter. "Our AU analyzers are known for high performance, speed and accuracy. Combining our chemistry systems with this PCT assay results in fast turnaround times, and enables rapid assessment of patients in these critical situations." Beckman Coulter has partnered with Diazyme Laboratories to distribute the PCT assay to ensure delivery of the broadest range of solutions for clinical laboratories. Diazyme Laboratories is a cGMP and ISO 13485 certified medical device manufacturer, utilizing proprietary enzyme and immunoassay technologies to develop diagnostic reagents in user-friendly formats. Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For over 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/beckman-coulter-diagnostics-expands-chemistry-menu-to-include-fda-cleared-procalcitonin-pct-300477167.html


Patent
Beckman Coulter | Date: 2016-03-23

A device coupling comprising:a female portion 220 of the device coupling having a recess 228;a shaft 218 having a tapered surface 214 formed at one end 216 of the shaft 218, the tapered surface 214 being insertable into the recess 228 of the female portion 220; anda screw 212 configured to pull the shaft 218 into the recess 228 of the female portion 220 and join the shaft 218 to the female portion 220.


Patent
Beckman Coulter | Date: 2015-08-26

A diagnostic instrument is disclosed. The diagnostic instrument may have a highly efficient probe washer station and/or may be able to sense whether there is a tube septum on a specimen tube to be sampled. The instrument may also be able to determine where the bottom of the tube is located. The probe washer station may have a flow of saline that is used to wash both the internal cavity and the external circumference of the probe.

Loading Beckman Coulter collaborators
Loading Beckman Coulter collaborators